Integrative pharmacology reveals the mechanisms of Erzhi Pill, a traditional Chinese formulation, against diabetic cardiomyopathy
- 1 October 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Ethnopharmacology
- Vol. 296, 115474
- https://doi.org/10.1016/j.jep.2022.115474
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Identification of putative biomarkers for prediabetes by metabolome analysis of rat models of type 2 diabetesMetabolomics, 2015
- AMPK Activation Inhibits Expression of Proinflammatory Mediators Through Downregulation of PI3K/p38 MAPK and NF-κB Signaling in Murine MacrophagesDNA and Cell Biology, 2015
- Activation of S1P1 Receptor Regulates PI3K/Akt/FoxO3a Pathway in Response to Oxidative Stress in PC12 CellsJournal of Molecular Neuroscience, 2014
- Oxidative Stress, Prooxidants, and Antioxidants: The InterplayBioMed Research International, 2014
- Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosisFood and Chemical Toxicology, 2014
- The Soluble Form of the EIAV Receptor Encoded by an Alternative Splicing Variant Inhibits EIAV Infection of Target CellsPLOS ONE, 2013
- Pre‐clinical diabetic cardiomyopathy: prevalence, screening, and outcomeEuropean Journal of Heart Failure, 2010
- Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic NephropathyCardiovascular Therapeutics, 2010
- The Characterization of High-Fat Diet and Multiple Low-Dose Streptozotocin Induced Type 2 Diabetes Rat ModelExperimental Diabetes Research, 2008
- Redox Control of Cell DeathAntioxidants and Redox Signaling, 2002